Haemonetics (HAE) Receivables - Other (2012 - 2018)
Haemonetics' (HAE) quarterly Receivables - Other came in at $5.0 million in Q1 2018, up 72.41% year-on-year from $2.9 million in Q1 2017, and little changed quarter-over-quarter from $5.0 million in Q4 2017.
Haemonetics (HAE) Receivables - Other (2012 - 2018) Analysis & Trends
Haemonetics' Receivables - Other history runs 3 years deep, the most recent figure standing at $5.0 million for Q1 2018.
- On a quarterly basis, Receivables - Other rose 72.41% year-over-year to $5.0 million in Q1 2018; TTM through Mar 2018 was $5.0 million, a 72.41% increase from a year earlier, with the FY2018 full-year figure at $5.0 million, up 72.41% from the prior year.
- Receivables - Other held at $5.0 million in Q1 2018 per HAE's latest filing, from $5.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $5.0 million in Q4 2017 and bottomed at $2.1 million in Q3 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Haemonetics | 3.50 Bn | 3.26 Bn | 198.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 5.00 Mn |
| Mar 31, 2018 | 5.00 Mn |
| Dec 30, 2017 | 5.00 Mn |
| Dec 30, 2017 | 5.00 Mn |
| Sep 30, 2017 | 2.10 Mn |
| Sep 30, 2017 | 2.10 Mn |
| Jul 1, 2017 | 2.90 Mn |
| Jul 1, 2017 | 2.90 Mn |
| Apr 1, 2017 | 2.90 Mn |
| Apr 1, 2017 | 2.90 Mn |
| Dec 29, 2012 | 8.20 Mn |
| Dec 29, 2012 | 8.20 Mn |
| Sep 29, 2012 | 100,000.00 |
| Sep 29, 2012 | 100,000.00 |
| Mar 31, 2012 | 3.20 Mn |
| Mar 31, 2012 | 3.20 Mn |